Windham-Bannister Susan Richards 4/A
4/A · Aridis Pharmaceuticals, Inc. · Filed Aug 29, 2019
Insider Transaction Report
Form 4/AAmended
Windham-Bannister Susan Richards
Director
Transactions
- Award
Stock Options
2019-07-12+35,000→ 35,000 totalExercise: $10.01Exp: 2029-07-12→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The reporting person is filing this Amendment to correct the vesting terms for the stock options that were reported in the original form 4. The stock options vest in 36 equal monthly installments beginning on June 5, 2019.